πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Theravance Biopharma Ireland Patents

Full USPTO pharma patent portfolio for Theravance Biopharma Ireland β€” grant dates, expiration, and drug cross-links.

Patents
635
Expiring ≀24m
58

Quick answer

Theravance Biopharma Ireland has 635 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 58 expire within 24 months β€” use filters for patent-cliff planning.

Page 9 of 14

  1. US 8101794

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8093354

    Process for preparing glycopeptide phosphonate derivatives

    Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8084417

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8080572

    Dual-acting antihypertensive agents

    Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8080565

    Substituted 4-amino-benzylpiperidine compounds

    Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8067439

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8053448

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8044045

    Indazole-carboxamide compounds as 5-HT4 receptor agonists

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8044195

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8039489

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8034946

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8030445

    Glycopeptide derivative

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8030502

    Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8017617

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8017783

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8013005

    Dual-acting antihypertensive agents

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8013152

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8008278

    Diarylmethyl and related compounds

    Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8003664

    Indazole-carboxamide compounds

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8003755

    Hydrochloride salts of a glycopeptide phosphonate derivative

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7994209

    3-phenoxymethylpyrrolidine compounds

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7994165

    Aryl aniline derivatives as Ξ²2 adrenergic receptor agonists

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7989484

    Dual-acting antihypertensive agents

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7981931

    Pharmaceutical compositions of short-acting sedative hypnotic agent

    Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7964730

    Amino-substituted ethylamino Ξ²2 adrenergic receptor agonists

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7960385

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7956054

    Dual-acting pyrazole antihypertensive agents

    Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7947710

    Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7943772

    Crystalline forms of an 8-azabicyclo(3.2.1)octane compound

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7939689

    Short-acting sedative hypnotic agents for anesthesia and sedation

    Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7910608

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7902148

    Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

    Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7902221

    Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7902220

    8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

    Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7897775

    Crystalline form of a benzimidazole-carboxamide medicinal compound

    Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7893256

    Azabicycloalkane compounds

    Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7888386

    3-(phenoxyphenylmethyl)pyrrolidine compounds

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7879879

    Biphenyl derivatives

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7879896

    Dual-acting imidazole antihypertensive agents

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7880010

    Crystalline forms of a dimethylphenyl compound

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7875629

    Quinolinone compounds as 5-HT4 receptor agonists

    Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7871997

    Cephalosporin compounds

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7868175

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7863309

    Dual-acting antihypertensive agents

    Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7858795

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7858792

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7858583

    Process for purifying glycopeptide phosphonate derivatives

    Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7858797

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Theravance Biopharma Ireland have?

635 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Theravance Biopharma Ireland patents expire?

58 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.